Lacticaseibacillus casei CNRZ1874 supplementation promotes M1 alveolar macrophage activation and attenuates Mycoplasma pneumoniae pneumonia
Lacticaseibacillus casei CNRZ1874 supplementation promotes M1 alveolar macrophage activation and attenuates Mycoplasma pneumoniae pneumonia
复制标题
DOI:
10.1093/jambio/lxad022
复制
发表时间:
2023-03-01
影响因子:
4
通讯作者:
Zhu,Cuiming
中科院分区:
文献类型:
--
作者:
Zhang,Naiyu;Zeng,Wuwei;Zhu,Cuiming
AimsTo evaluate the protective effect of intestinal supplementation withLacticaseibacillus caseiCNRZ1874 on the inflammatory response induced byMycoplasma pneumoniaein C57BL/6 J mice, and provide a potential strategy for alleviatingM. pneumoniaepneumonia.Methods and resultsC57BL/6 J mice were gavaged withL. caseiCNRZ1874 or PBS for 7 consecutive days, and then infected withM. pneumoniaeon day 8. Treatment withL. caseiCNRZ1874 significantly reducedM. pneumoniaeloads in the lungs and alleviated the lung inflammation on day 3 and 10 after pathogen infection. Importantly, oral administration withL. caseiCNRZ1874 promoted M1 alveolar macrophages activation as evidenced by increased expression of iNOS, TNF-α, and CXCL1, while inhibited M2 alveolar macrophages activation as the expression of Arg1 and Chi3l3 were significantly decreased. In consistent with the M1 alveolar macrophages activation and enhanced mycoplasma clearance, the level of TNF-α was increased while the level of IL-4 was decreased in lung tissue from theL. caseiCNRZ1874 group compared with the control group. However, oral administration withL. caseiCNRZ1874 may not influence adaptive immunity induced byM. pneumoniaeas evaluated byM. pneumoniaespecific antibodies and T cells responses in spleen.ConclusionsIntestinal supplementation withL. caseiCNRZ1874 can promote M1 alveolar macrophages activation, which contributes to the clearance ofM. pneumoniaeand attenuation ofM.pneumoniaepneumonia.